tm logo

Monitor this mark

View On USPTO

LENVIMA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 01 Sep 2021

Last Applicant/ Owned by

Eisai R&D Management Co., Ltd.

6-10, Koishikawa 4-chome, Bunkyo-ku

Tokyo

JP

112-8088

Serial Number

85778136 filed on 13th Nov 2012

Registration Number

4744029 registered on 26th May 2015

in the Principal Register

Correspondent Address

Mainak H. Mehta

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP

Suite 2200

San Diego, CA 92101

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LENVIMA

Pharmaceutical preparations and substances for the treatment of oncological diseases

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for the treatment of oncological diseases

First Use Date in General

26th Feb 2015

First Use Date in Commerce

26th Feb 2015

Mark Details

Serial Number

No 85778136

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 120776ERD017

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
26th May 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01st Sep 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01st Sep 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01st Sep 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th May 2021TEAS SECTION 8 & 15 RECEIVED
26th May 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
26th May 2015REGISTERED-PRINCIPAL REGISTER
21st Apr 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
20th Apr 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18th Apr 2015STATEMENT OF USE PROCESSING COMPLETE